As of Mar 03
| +1.37 / +10.07%|
The 5 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 18.00, with a high estimate of 20.00 and a low estimate of 13.00. The median estimate represents a +20.24% increase from the last price of 14.97.
The current consensus among 4 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.